SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022085
Filing Date
2022-08-11
Accepted
2022-08-11 16:16:15
Documents
84
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1333678
2 ex10-1.htm EX-10.1 102884
3 ex31-1.htm EX-31.1 17591
4 ex32-1.htm EX-32.1 7373
  Complete submission text file 0001493152-22-022085.txt   8319054

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lctx-20220630.xsd EX-101.SCH 65149
6 XBRL CALCULATION FILE lctx-20220630_cal.xml EX-101.CAL 72575
7 XBRL DEFINITION FILE lctx-20220630_def.xml EX-101.DEF 274400
8 XBRL LABEL FILE lctx-20220630_lab.xml EX-101.LAB 488437
9 XBRL PRESENTATION FILE lctx-20220630_pre.xml EX-101.PRE 392993
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1623393
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 221156094
SIC: 2836 Biological Products, (No Diagnostic Substances)